Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Synthesis Methods of Lenvatinib Mesylate API

    07 Aug 2024

    // PRESS RELEASE

    Sourcing Strategies for High-Quality Gadobutrol API

    24 Jul 2024

    // PRESS RELEASE

    Quality Control in Parecoxib Sodium API Production

    16 Jul 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI China

    Booth #W1G36

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/prostaglandin-market-to-cross-us-1-27-bn-by-2035-liquidia-s-yutrepia-okayed-for-pulmonary-hypertension
    Menu

    Sichuan Qingmu Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Sichuan Qingmu Pharmaceutical Co., Ltd

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #W1G36

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-09-07

    Sichuan Qingmu Pharmaceutical

    City : Meishan

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-09-07

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #W1G36

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-09-07

    Sichuan Qingmu Pharmaceutical

    City : Meishan

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-09-07

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Sichuan Qingmu Pharmaceutical and get a quotation

    Sichuan Qingmu Pharmaceutical is a supplier offers 30 products (APIs, Excipients or Intermediates).

    Find Rotigotine bulk with DMF, CEP, JDMF offered by Sichuan Qingmu Pharmaceutical

    Find Bisoprolol Fumarate bulk with CEP, JDMF offered by Sichuan Qingmu Pharmaceutical

    Find Dabigatran Etexilate Mesylate bulk with DMF offered by Sichuan Qingmu Pharmaceutical

    Find Lemborexant bulk with DMF offered by Sichuan Qingmu Pharmaceutical

    Find Lenvatinib Mesylate bulk with DMF offered by Sichuan Qingmu Pharmaceutical

    Find Methylene Blue bulk with DMF offered by Sichuan Qingmu Pharmaceutical

    Find Sugammadex Sodium bulk with DMF offered by Sichuan Qingmu Pharmaceutical

    Find Afoxolaner bulk offered by Sichuan Qingmu Pharmaceutical

    Find Atinvicitinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Axitinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Brexpiprazole bulk offered by Sichuan Qingmu Pharmaceutical

    Find Cabozantinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Emodepside bulk offered by Sichuan Qingmu Pharmaceutical

    Find Etoricoxib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Firocoxib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Fluralaner bulk offered by Sichuan Qingmu Pharmaceutical

    Find Fruquintinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Ilunocitinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Ixazomib Citrate bulk offered by Sichuan Qingmu Pharmaceutical

    Find Lotilaner bulk offered by Sichuan Qingmu Pharmaceutical

    Find Maropitant bulk offered by Sichuan Qingmu Pharmaceutical

    Find Mirogabalin Besylate bulk offered by Sichuan Qingmu Pharmaceutical

    Find Nilotinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Niraparib Tosylate bulk offered by Sichuan Qingmu Pharmaceutical

    Find Oclacitinib Maleate bulk offered by Sichuan Qingmu Pharmaceutical

    Find Omadacycline bulk offered by Sichuan Qingmu Pharmaceutical

    Find Ponatinib bulk offered by Sichuan Qingmu Pharmaceutical

    Find Ruxolitinib Phosphate bulk offered by Sichuan Qingmu Pharmaceutical

    Find Sarolaner bulk offered by Sichuan Qingmu Pharmaceutical

    Find SN38 API bulk offered by Sichuan Qingmu Pharmaceutical

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.